Is Medline Inc. (MDLN) A Good Stock To Buy Now?
Is MDLN a good stock to buy? We came across a bullish thesis on Medline Inc. on The Pursuit of Compounding’s Substack. In this article, we will summarize the bulls’ thesis on MDLN.
Medline Inc. (MDLN)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $29.00 | 12,586,206 | $364,999,974.00 | 27,241,378 | 2025-12-18 | Filing | |
| $29.00 | 2,586,206 | $74,999,974.00 | 2,586,206 | 2025-12-18 | Filing | |
| $29.00 | 137,931 | $3,999,999.00 | 137,931 | 2025-12-18 | Filing | |
| $29.00 | 2,441,379 | $70,799,991.00 | 2,441,379 | 2025-12-18 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $40.51 | 1,060,095 | $42,942,328.26 | 7,895,482 | 2026-03-10 | Filing | |
| $40.51 | 9,801,455 | $397,037,339.14 | 75,931,567 | 2026-03-10 | Filing | |
| $40.51 | 629,933 | $25,517,325.96 | 4,176,227 | 2026-03-10 | Filing | |
| $40.51 | 14,639,754 | $593,027,155.03 | 558,307 | 2026-03-10 | Filing | |
| $41.00 | 26,105,840 | $1,070,339,440.00 | 127,567,724 | 2026-03-10 | Filing |
News See All
10 Top Stocks Fund Managers Are Loading Up On in 2026
With the macroeconomic uncertainty looming over the market, the spotlight on institutional positioning gets brighter.
Brown Advisory Mid-Cap Growth Strategy Bets on Medline (MDLN) in IPO
Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
11 Best Young Stocks to Buy and Hold for 20 Years
On March 10, WilmerHale released its 2026 IPO report, highlighting an overview and outlook of the US IPO market.
Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO
Medline Inc. (NASDAQ:MDLN) is one of the best NASDAQ stocks to buy according to hedge funds.
15 Best NASDAQ Stocks to Buy According to Hedge Funds
On February 26, Jay Woods of Freedom Capital Markets, Seana Smith of Global X ETFs, and Eric Mandl of Guggenheim Securities joined CNBC to suggest that strong tech results eased AI fears, but volatility...
Jim Cramer Recently Looked at These 25 Stocks
We're in critical short supply for all sorts of chips that are needed in the data center... It wasn't easy to forecast this boom, I admit, as recently as one year ago.
15 Stocks Jim Cramer Talked About
“When the market flies like it's been doing, at least until today, you need to be selective.
"I Was Very Impressed" by Medline (MDLN)'s IPO, Says Jim Cramer
Medical supplies and instrument firm Medline Inc. (NASDAQ:MDLN)’s shares underwent their public listing earlier this month. The firm raised $6.26 billion in the offering. Medline Inc.
10 Stocks Jim Cramer Talked About
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer discussed the latest inflation report.
Hedge Fund Resource Center